These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16680063)

  • 1. Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension.
    Derosa G; Cicero AF; D'Angelo A; Tinelli C; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Fogari R
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):508-12. PubMed ID: 16680063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidaemic hypertensive patients.
    Coban E; Ozdogan M; Yazicioglu G; Sari R
    Int J Clin Pract; 2005 Apr; 59(4):415-8. PubMed ID: 15853856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
    J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum nitric oxide metabolite (NO(x)) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls.
    Higashino H; Miya H; Mukai H; Miya Y
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):725-31. PubMed ID: 17600548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.
    Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
    Fundam Clin Pharmacol; 2012 Dec; 26(6):701-11. PubMed ID: 21913974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide overproduction derived from inducible nitric oxide synthase increases cardiomyocyte apoptosis in human atrial fibrillation.
    Han W; Fu S; Wei N; Xie B; Li W; Yang S; Li Y; Liang Z; Huo H
    Int J Cardiol; 2008 Nov; 130(2):165-73. PubMed ID: 18585800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of high-sensitivity C-reactive protein in bronchial asthma.
    Sahoo RC; Acharya PR; Noushad TH; Anand R; Acharya VK; Sahu KR
    Indian J Chest Dis Allied Sci; 2009; 51(4):213-6. PubMed ID: 20073372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The nitric oxide system in patients with arterial hypertension living in high mountains].
    Kurdanova MKh; Beslaneev IA; Batyrbekova LM; Berkhamova ZA; Sarbasheva AKh; Kurdanov KhA
    Ter Arkh; 2007; 79(12):25-8. PubMed ID: 18220026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP).
    Chiu-Braga YY; Hayashi SY; Schafranski M; Messias-Reason IJ
    Int J Cardiol; 2006 May; 109(2):275-6. PubMed ID: 15946754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade inflammation in white-coat hypertension.
    Ozdogan M; Bozcuk H; Coban E
    Med Sci Monit; 2007 Dec; 13(12):CR570-3. PubMed ID: 18049438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community.
    Nakhai-Pour HR; Grobbee DE; Bots ML; Muller M; van der Schouw YT
    J Hum Hypertens; 2007 Dec; 21(12):949-55. PubMed ID: 17597799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease.
    Aguilar EM; Miralles Jde H; González AF; Casariego CV; Moreno SB; García FA
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):443-7. PubMed ID: 19211277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients.
    Tsioufis C; Dimitriadis K; Selima M; Thomopoulos C; Mihas C; Skiadas I; Tousoulis D; Stefanadis C; Kallikazaros I
    Eur Heart J; 2007 May; 28(9):1162-9. PubMed ID: 17446227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxazosin improves insulin sensitivity in hypertensive patients.
    Kageyama S; Yamamoto J; Mimura A; Sakurai T; Ishibashi K; Aihara K; Taniguchi I; Ito K; Isogai Y
    Clin Ther; 1993; 15(5):829-37. PubMed ID: 8269449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term organ protection by doxazosin and/or quinapril as antihypertensive therapy.
    Gallego-Delgado J; Lazaro A; Gomez-Garre D; Osende JI; Gonzalez-Rubio ML; Herraiz M; Manzarbeitia F; Fortes J; Fernandez-Cruz A; Egido J
    J Nephrol; 2006; 19(5):588-98. PubMed ID: 17136686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of doxazosin gastrointestinal therapeutic system on platelet degranulation and platelet-leukocyte microaggregate formation induced by physiologic shear stress in hypertension.
    Labiós M; Martínez M; Gabriel F; Guiral V; Aznar J
    Thromb Res; 2006; 118(4):447-53. PubMed ID: 16242179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters in Indian type 2 diabetic males.
    Sarangi R; Padhi S; Mohapatra S; Swain S; Padhy RK; Mandal MK; Patro SK; Kumar S
    Diabetes Metab Syndr; 2012; 6(1):9-14. PubMed ID: 23014248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of allergic rhinitis can improve blood pressure control.
    Magen E; Yosefy C; Viskoper RJ; Mishal J
    J Hum Hypertens; 2006 Nov; 20(11):888-93. PubMed ID: 16967045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM; Lin MS; Chang NC
    Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.